At 12.6% CAGR, Global Vaccines Market Size to Hit USD 153.49 Bn in 2028, Says Brandessence Market Research

LONDON, Jan. 3, 2022 /PRNewswire/ -- Global Vaccines Market is valued at USD 56.98 Billion in 2021 and expected to reach USD 153.49 Billion by 2028 with a CAGR of 14.1% over the forecast period

The global disruption caused by Covid-19 pandemic, and new threats by variants like Omnicron remain key drivers of growth for the global vaccine market. Globally, major regions like the North America, EU, and Asia Pacific are undertaking initiatives to provide booster shots to population. The limited time-period immunity offered by many current vaccines, and large threats to lives, and livelihoods continue to increase threats for global population, and the global economy. The World Health Organization estimated that in 2019, there were over 5.5 billion doses administered globally. Apart from Covid-19, polio, tetanus, measles, and diphtheria vaccine promise major growth around the globe in 2020-2028 period. Moreover, commercialization promises also remains high as most procurement comes from self-procuring middle-income countries. The growing vaccine manufacturer in the Asia Pacific region, and development of new vaccines like rotavirus, pneumococcal conjugate, and human papillomavirus vaccine promise new opportunities in cost-reduction, and establishment of new supply chains, and distribution logistics.

Get Sample Copy of This Premium Report@ https://brandessenceresearch.com/requestSample/PostId/276

Global Vaccines Market Companies Covered :

Global Vaccines Market reports cover prominent players like Glaxo Smith Kline plc, Pfizer Inc., Merck & Co. Inc., Sanofi, CSL Limited, Daiichi Sankyo Company Limited, Bavarian Nordic,Panacea Biotech, Protein Sciences Corporation, AstraZeneca, Emergent BioSolutions Inc. , Johnson & Johnson, Medimmune, LLC, AstellasPharma Inc., Serum Institute of India, Bavarian Nordic, Abbott, Bristol-Myers Squibb,Novavax Inc., Gritstone Oncology, PaxVax Corporation.,Bharat Biotech., VBI Vaccines Inc.,Dynavax Technologies Corporation, Immunomic Therapeutics, Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Prokarium, and ImmunoBiology Ltd., Mitsubishi Tanabe Pharma Corporation, ,Janssen Pharmaceutical Company,Takeda Pharmaceuticals Company Ltd., Valeant Pharmaceuticals International, Inc., China National Biotech, Tiantan, Hualan, Kangtai,Hissen andJintan.

Market Segmentation of Global Vaccine Market

By Technology

• Conjugate Vaccines
• Inactivated Vaccines
• Live Attenuated Vaccines
• Toxoid Vaccines
• Recombinant Vaccines
• Others

By Indication

• Influenza
• Pneumococcal Disease
• Meningococcal Disease
• Human Papilloma Virus
• Rotavirus
• Varicella
• Diphtheria-Pertussis-Tetanus (DTP)
• Polio
• Hepatitis
• Measles-Mumps- Rubella (MMR)
• Others

By End User

• Pediatric Vaccines
• Adult Vaccines
• Traveller Vaccines
• Others

Purchase this Premium Report @ https://brandessenceresearch.com/Checkout?report_id=276

Global Vaccine Market: Key Opportunities

The global vaccine market accounted for USD 33 billion in valuation in 2019. This valuation is roughly 2% of the global pharmaceutical market. Moreover, while demand for middle-income countries like India, and China continues to be strongest, the large value proposition, over 68% is generated in high-income countries. Vaccines like Diptheria, pneumococcal conjugate, and tetanus, and human papillomavirus vaccine remain the largest value acquiring vaccines, globally. The growing demand in new regions like Asia Pacific, Middle East & Africa, with global partnerships like GAVI remain promising driver of growth for the global vaccine market.  

Vaccine procurement partnerships like SIA remain the highest procurer in the global vaccine market by volume. Vaccines like Bivalent OPV or Oral Polio Vaccine remains the highest in demand, globally, with Diptheria, and MCV remaining second- highest, and third-highest globally. Furthermore, PCV is likely to witness highest growth in the upcoming future, as growing demand for three-dose series, and increased conformity to WHO recommendations remain promising drivers of growth. Similarly, HPV also remains a promising vaccine for future growth, as growing end to supply constraints, and increased global initiatives to eliminate the virus remain key drivers to growth. The vaccine for measles is likely to be replaced by MR and MMR vaccines containing rubella, predicting a decline for the measles vaccine.

1. MRNA Vaccines And Therapeutics Market By Type (Standardization Of Cancer Treatment MRNA Vaccine, Individualized Cancer Treatment MRNA Vaccine, Infectious Disease Treatment MRNA Vaccine, Infection Prevention MRNA Vaccine) By End-Users (Infectious Disease, Cancer, Other) Forecasts, 2021 – 2027 - mRNA Vaccines & Therapeutics Market is expected to reach USD 1599.2 Million by 2027 with a CAGR of 29.83%
2. Rabies Vaccine Market Size, Share & Trends Analysis Report By Product Type (Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, Baby Hamster Vaccine, Others) By Vaccine (Post-Exposure Prophylaxis, Neutral Vaccine, Non-Neutral Vaccine, Pre-Exposure Vaccine, Others) By End User (Hospitals, Clinics, Others) Based On Region, And Segment Forecasts, 2021 – 2027 - Global Rabies Vaccine Market is expected to reach USD 1292.62 Million by the end of 2027 with the CAGR of 5.2% during the Forecast Period.
3. Swine Flu Vaccine Market By Vaccine Type (Intranasal, Toxoid, Conjugate, Inactivated Vaccine, Attenuated Vaccine, Others) By Brand (Influgen, Agripal, Nasovac, Fiuarix, Vaxigrip, Others) By End User (Hospital, Clinic, Others) Forecasts, 2021 – 2027 - Global Swine Flu Vaccine Market is expected to reach USD 17.26 Billion by the end of 2027 with the CAGR of 5.78% during Forecast Period.
4. Zika Virus Vaccine Market By Type (Preventive Vaccine, Therapeutics Vaccine, Other) By End User (Clinics, Hospitals, Research Institutes, Others) Forecasts, 2021 – 2027 - Global Zika Virus Vaccine Market was worth of USD 14.58 Billion in 2017 and it is expected to reach USD 23.09 Billion by the end of 2027 with the CAGR of 4.7% during Forecast Period.
5. Pediatric Vaccines Market By Application (Influenza, Measles & Rubella, Polio, Hepatitis B, Others) By Type (Multivalent Vaccine, Monovalent Vaccine) By Technology (Subunits, Inactivated Virus, Recombinant, Conjugates , Others) - Global Pediatric Vaccines Market is expected to reach USD 67.17 Billion by the end of 2027 with the CAGR of 7.5% during the Forecast Period.
6. Human Vaccines Market By Type (Combination, Attenuated, Inactivated, Conjugate, Recombinant, Others) By Product (Rotavirus, Hepatitis, Influenza, Typhoid, Rubella, Others) By Distribution Channel (Hospital, Drugstores, Others) Forecasts, 2021 – 2027 - Global Human Vaccines Market was worth of USD 35.42 Billion in 2017 and it is expected to reach USD 83.54 Billion by the end of 2027 with the CAGR of 9.32% during the Forecast Period.
7. Cancer Vaccines Market By Type (Therapeutic Cancer Vaccine, Preventive Cancer Vaccine, Others) By Application (Prostate Cancer, Cervical Cancer, Others) By Technology (Whole-Cell Cancer Vaccine, DNA Cancer Vaccine, Recombinant Cancer Vaccine, Others) Forecasts, 2021 – 2027 - Global Cancer Vaccines Market was worth of USD 4.93 Billion in 2020 and it is expected to reach USD 12.64 Billion by the end of 2027 with a CAGR of 9.8% during the Forecast Period.
8. Conjugate Vaccine Market By Indication (Meningococcal, Influenza, Pneumococcal, Others), By Type (Monovalent, Multivalent, Others), By End User (Adults, Pediatrics) - The Global Conjugate Vaccine Market was worth of USD 15.58 Billion in 2020 and it is expected to reach USD 29.60 Billion by the end of 2027 with a CAGR of 9.6% during the Forecast Period.

On Special Requirement the above Market Reports is also available for below regions:

North America

• U.S, Canada

Europe

• Germany, France, U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe

Asia-Pacific

• South Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC

Latin America

• Mexico, Colombia, Brazil, Argentina, Peru, Rest of Latin America

Middle East and Africa

• Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA

i-Factor: Live Market intelligence platform

I-Factor is our guaranteed seal to keep our clients ahead of the competition, always. This knowledge platform delivers real-time updates on key economic indicators, competitive landscape, changing demand, trends, customized regional insights, and more. The platform visualizes key data points to help make decision making agile, trustworthy, and holistic.  Register for free trail here @ https://brandessenceresearch.com/i-factor/login/userRegister

For All Trending Reports of Vaccine: https://brandessenceresearch.com/Category/Vaccines/

Brandessence Market Research & Consulting Pvt ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Website: https://brandessenceresearch.com 
Blog:  Pea Protein companies

Mr. Vishal Sawant 
Email: [email protected] 
Email: [email protected] 
Corporate Sales: +44-2038074155
Asia Office: +917447409162

SOURCE Brandessence Market Research And Consulting Private Limited